Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma

被引:3
作者
Lee, Yi-Te [1 ]
Karim, Mohammad A. [2 ]
Kum, Hye Chung [2 ]
Park, Sulki [2 ]
Rich, Nicole E. [3 ]
Noureddin, Mazen [4 ,5 ]
Singal, Amit G. [3 ]
Yang, Ju Dong [4 ,5 ,6 ,7 ]
机构
[1] Univ Calif Los Angeles, Calif Nanosyst Inst, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol ogy, Los Angeles, CA USA
[2] Texas A&M Univ, Sch Publ Hlth, Populat Informat Lab, College Stn, TX USA
[3] Univ Texas Southwestern Med Ctr, Div Digest & Liver Dis, Dallas, TX USA
[4] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, Los Angeles, CA USA
[5] Comprehens Transplant Ctr, Cedars Sinai Med Ctr, Los Angeles, CA USA
[6] Cedars Sinai Med Ctr, Samuel Oschin Comprehen s Canc Inst, Los Angeles, CA USA
[7] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Comprehens Transplant Ctr, Karsh Div Gastroenterol & Hepatol, 8900 Beverly Blvd, Los Angeles, CA 90048 USA
基金
美国国家卫生研究院;
关键词
Liver cirrhosis; NAFLD; Hepatocellular carcinoma; Cancer screening; HEPATITIS-B;
D O I
10.3350/cmh.2022.0450
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is often asymptomatic and can go undiagnosed for years, leading to underuse of HCC surveillance in clinical practice. We characterized the frequency and associated factors of unrecognized cirrhosis in a national sample of patients with HCC from the United States.Methods: HCC patients aged 68 years and older, diagnosed during 2011 to 2015 were included from the SEER -Medicare Linked Database. If cirrhosis was diagnosed within 6 months immediately preceding HCC diagnosis or after HCC diagnosis, cases were categorized as unrecognized cirrhosis. Factors associated with unrecognized cirrhosis were identified using logistic regression analyses. Factors associated with overall survival were evaluated using Cox regression analyses.Results: Among 5,098 HCC patients, 74.8% patients had cirrhosis. Among those with cirrhosis, 57.4% had unrecognized cirrhosis, with the highest proportion (76.3%) among those with NAFLD-related HCC. Male sex (aOR: 2.12, 95% CI: 1.83-2.46), non-Hispanic Black race (aOR: 1.93, 95% CI: 1.45-2.57), and NAFLD etiology (aOR: 4.46, 95% CI: 3.68-5.41) were associated with having unrecognized cirrhosis. Among NAFLD-related HCC patients, male sex (aOR: 2.32, 95% CI: 1.71-3.14) was associated with unrecognized cirrhosis. Unrecognized cirrhosis was independently associated with worse overall survival (aHR: 1.17, 95% CI: 1.08-1.27) compared to recognized cirrhosis.Conclusions: Unrecognized cirrhosis is common in NAFLD-related HCC, particularly among male and Black patients, highlighting these groups as important intervention targets to improve HCC surveillance uptake and outcomes. (Clin Mol Hepatol 2023;29:453-464)
引用
收藏
页码:453 / 464
页数:12
相关论文
共 35 条
[1]   Poor Awareness of Liver Disease Among Adults With NAFLD in the United States [J].
Alqahtani, Saleh A. ;
Paik, James M. ;
Biswas, Rakesh ;
Arshad, Tamoore ;
Henry, Linda ;
Younossi, Zobair M. .
HEPATOLOGY COMMUNICATIONS, 2021, 5 (11) :1833-1847
[2]   Etiology and Outcomes of Hepatocellular Carcinoma in an Ethnically Diverse Population: The Multiethnic Cohort [J].
Barzi, Afsaneh ;
Zhou, Kali ;
Wang, Songren ;
Dodge, Jennifer L. ;
El-Khoueiry, Anthony ;
Setiawan, Veronica Wendy .
CANCERS, 2021, 13 (14)
[3]   Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma [J].
Cho, Yuri ;
Kim, Bo Hyun ;
Park, Joong-Won .
CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 :S220-S227
[4]   American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD) [J].
Cusi, Kenneth ;
Isaacs, Scott ;
Barb, Diana ;
Basu, Rita ;
Caprio, Sonia ;
Garvey, W. Timothy ;
Kashyap, Sangeeta ;
Mechanick, Jeffrey I. ;
Mouzaki, Marialena ;
Nadolsky, Karl ;
Rinella, Mary E. ;
Vos, Miriam B. ;
Younossi, Zobair .
ENDOCRINE PRACTICE, 2022, 28 (05) :528-562
[5]   Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death [J].
Degos, F ;
Christidis, C ;
Ganne-Carrie, N ;
Farmachidi, JP ;
Degott, C ;
Guettier, C ;
Trinchet, JC ;
Beaugrand, M ;
Chevret, S .
GUT, 2000, 47 (01) :131-136
[6]  
European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
[7]  
Ge Xiaojun, 2020, BMJ Open, V10, pe036663, DOI 10.1136/bmjopen-2019-036663
[8]   Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm? [J].
Hanouneh, Ibrahim A. ;
Alkhouri, Naim ;
Singal, Amit G. .
CLINICAL AND MOLECULAR HEPATOLOGY, 2019, 25 (03) :264-269
[9]   Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in the United States [J].
Karim, Mohammad A. ;
Singal, Amit G. ;
Kum, Hye Chung ;
Lee, Yi-Te ;
Park, Sulki ;
Rich, Nicole E. ;
Noureddin, Mazen ;
Yang, Ju Dong .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (03) :670-+
[10]   The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases [J].
Kramer, J. R. ;
Davila, J. A. ;
Miller, E. D. ;
Richardson, P. ;
Giordano, T. P. ;
El-Serag, H. B. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (03) :274-282